Naphazoline HCI And Pheniramine Maleate NDC 59390-177

NDC codes

FDA NDC Directory

Product NDC (as listed)59390-177Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59390-0177Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59390-177-13	59390017713	15 mL in 1 BOTTLE, DROPPER (59390-177-13)Marketed from Oct 6, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naphazoline HCI And Pheniramine Maleate
Generic name (nonproprietary): naphazoline hydrochloride , pheniramine maleate
Active ingredients: Naphazoline hydrochloride — .27 mg/mLPheniramine maleate — 3.15 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Altaire Pharmaceuticals Inc.
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078208
Marketing start: Oct 6, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 59390-177_b78fd969-ee4c-0ea0-e053-2a95a90a480dSPL ID b78fd969-ee4c-0ea0-e053-2a95a90a480dSPL set ID 5649c6e2-966f-44d9-b57e-5bb988eb373dRxCUI 1043704UNII MZ1131787D, NYW905655B

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459390017713 followed by a unit qualifier and the quantity

Package 59390-0177-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 28, 2020.

Indications (excerpt from the label)

Uses: temporarily relieves itching and redness caused by pollen, ragweed, grass, animal hair and dander.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)